Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Novavax Inc (NASDAQ: NVAX)

$1.02 USD $0.00 (0.00%)
Last Price $1.02
Net Change $0 (0%)
Bid $0.93
Ask Price $1.04
Open Price $1.03
Previous Close Price $1.02
High Price $1.07
Low Price $0.96
Number of Trades 10,608
Volume 7,464,100
Fifty Two Week High $8.49 (2016-09-15)
Fifty Two Week Low $0.73 (2017-05-08)
Average Daily Volume 6,585,283
Share Outstanding 271,950 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.16 (2017-05-08)
2nd Quarter Earnings $-0.21 (2017-02-27)
3nd Quarter Earnings $-0.24 (2016-11-09)
4th Quarter Earnings $-0.29 (2016-08-09)
PE Ratio $0
EPS Growth $40.22
Recent Earnings $-0.16
Annual EPS $-0.9
Last Quarter EPS $
Market Capitalization $0.28B
Insider Shareholders % 0.035%
Annual Revenue $0B
No. Shares Outstanding 271,950
Inst. Shareholder % 49.99%
Annual Net Income $-0.25B
TTM Net Profit Margin $-1465.87
1-Year Return -81.45%
3-Year Return -80.12%
5-Year Return -19.69%
5-Year Revenue Growth 4.49%
5-Year Earnings Growth 442.11%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 40.220001%
Dividends per Share $
Stock Split Ratio
Beta 2.01
NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as vehicles for the delivery of a wide variety of drugs and other therapeutic products, including certain hormones, anti-bacterial and anti-viral products and vaccine adjuvants.